Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Quinoline NPY antagonists under study at Roche

May 6, 2003

Novel CETP inhibitors identified by Bayer scientists

May 6, 2003

Pyrimidine-based insulin secretagogues prepared and tested at Yamanouchi

May 6, 2003

Eculizumab reported effective in paroxysmal nocturnal hemoglobinuria

May 6, 2003

Phase II trials of human GLP-1 analogue completed at Novo Nordisk

May 5, 2003

FDA approves Aldurazyme for MPS I

May 5, 2003

FDA approves first treatment for Fabry's disease

May 5, 2003

Amylin fragments reported to stimulate bone growth

May 5, 2003

Thiazolidine DPP-IV inhibitors described by Mitsubishi Pharma

May 5, 2003

Topical testosterone improves erectile response in male hypogonadism unresponsive to sildenafil

May 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...